IBD activity was evaluated using endoscopic and clinical examinations.
In total, 246 patients with IBD (131 with Ulcerative colitis (UC) and 115 with Crohn’s disease (CD)) and 369 healthy controls were recruited for this retrospective study.
In this study, our aim was to identify noninvasive, low cost, and convenient biomarkers for identifying endoscopic IBD activity. However, because the procedure is costly and invasive, endoscopy is not suitable for frequently monitoring intestinal inflammation. Endoscopy is currently recognized as the gold standard for assessing inflammatory bowel disease (IBD) severity.
